Mrv1652301121721432D 18 20 0 0 1 0 999 V2000 -0.3186 1.7471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0331 1.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9636 0.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3186 0.0971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3959 0.5096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3959 1.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1103 0.0971 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.8949 0.3520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3799 -0.3154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8949 -0.9829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1103 -0.7279 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.3959 -1.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3186 -0.7279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9636 -1.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7679 -1.0587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1259 -0.3154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.7679 0.4279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3834 0.0000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 1 6 1 0 0 0 0 5 7 1 0 0 0 0 7 8 1 1 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 11 10 1 1 0 0 0 7 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 4 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 3 17 1 0 0 0 0 M END > DBSALT002131 > drugbank > Cl.C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1 > InChI=1S/C15H20N2.ClH/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17;/h1,3,6,12-13,16H,2,4-5,7-10H2;1H/t12-,13-;/m0./s1 > PYPPENBDXAWXJC-QNTKWALQSA-N > C15H21ClN2 > 264.8 > 264.1393264 > 2 > 39 > 26.719101618502208 > 1 > 1 > 0 > 1 > (12R,16S)-7,10-diazatetracyclo[8.6.1.0^{5,17}.0^{12,16}]heptadeca-1,3,5(17)-triene hydrochloride > 2.80 > 2.5854054173333334 > -2.96 > 0 > 4 > 1 > 8.902771040523596 > 15.27 > 71.4952 > 0 > 1 > 2.52e-01 g/l > (12R,16S)-7,10-diazatetracyclo[8.6.1.0^{5,17}.0^{12,16}]heptadeca-1,3,5(17)-triene hydrochloride > 1 > DBSALT002131 > Vabicaserin Hydrochloride > DB12071 > Vabicaserin > 887258-94-8 > 2759C7222C $$$$